177 related articles for article (PubMed ID: 15470494)
21. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2.
Macías-Silva M; Hoodless PA; Tang SJ; Buchwald M; Wrana JL
J Biol Chem; 1998 Oct; 273(40):25628-36. PubMed ID: 9748228
[TBL] [Abstract][Full Text] [Related]
22. Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes.
Liu F; Pouponnot C; Massagué J
Genes Dev; 1997 Dec; 11(23):3157-67. PubMed ID: 9389648
[TBL] [Abstract][Full Text] [Related]
23. TGF-β-induced growth inhibition in B-cell lymphoma correlates with Smad1/5 signalling and constitutively active p38 MAPK.
Bakkebø M; Huse K; Hilden VI; Smeland EB; Oksvold MP
BMC Immunol; 2010 Nov; 11():57. PubMed ID: 21092277
[TBL] [Abstract][Full Text] [Related]
24. Regulation mechanisms of retinal pigment epithelial cell migration by the TGF-beta superfamily.
Mitsuhiro MR; Eguchi S; Yamashita H
Acta Ophthalmol Scand; 2003 Dec; 81(6):630-8. PubMed ID: 14641267
[TBL] [Abstract][Full Text] [Related]
25. Endoglin null endothelial cells proliferate faster and are more responsive to transforming growth factor beta1 with higher affinity receptors and an activated Alk1 pathway.
Pece-Barbara N; Vera S; Kathirkamathamby K; Liebner S; Di Guglielmo GM; Dejana E; Wrana JL; Letarte M
J Biol Chem; 2005 Jul; 280(30):27800-8. PubMed ID: 15923183
[TBL] [Abstract][Full Text] [Related]
26. Bcl-2 overexpression leads to increases in suppressor of cytokine signaling-3 expression in B cells and de novo follicular lymphoma.
Vanasse GJ; Winn RK; Rodov S; Zieske AW; Li JT; Tupper JC; Tang J; Raines EW; Peters MA; Yeung KY; Harlan JM
Mol Cancer Res; 2004 Nov; 2(11):620-31. PubMed ID: 15561778
[TBL] [Abstract][Full Text] [Related]
27. TGF-beta signal transduction.
Massagué J
Annu Rev Biochem; 1998; 67():753-91. PubMed ID: 9759503
[TBL] [Abstract][Full Text] [Related]
28. The adaptor molecule Disabled-2 links the transforming growth factor beta receptors to the Smad pathway.
Hocevar BA; Smine A; Xu XX; Howe PH
EMBO J; 2001 Jun; 20(11):2789-801. PubMed ID: 11387212
[TBL] [Abstract][Full Text] [Related]
29. TGFbeta-stimulated Smad1/5 phosphorylation requires the ALK5 L45 loop and mediates the pro-migratory TGFbeta switch.
Liu IM; Schilling SH; Knouse KA; Choy L; Derynck R; Wang XF
EMBO J; 2009 Jan; 28(2):88-98. PubMed ID: 19096363
[TBL] [Abstract][Full Text] [Related]
30. Monocytes and T cells cooperate to favor normal and follicular lymphoma B-cell growth: role of IL-15 and CD40L signaling.
Epron G; Ame-Thomas P; Le Priol J; Pangault C; Dulong J; Lamy T; Fest T; Tarte K
Leukemia; 2012 Jan; 26(1):139-48. PubMed ID: 21788945
[TBL] [Abstract][Full Text] [Related]
31. A kinase-inactive type II TGFbeta receptor impairs BMP signaling in human breast cancer cells.
Dumont N; Arteaga CL
Biochem Biophys Res Commun; 2003 Jan; 301(1):108-12. PubMed ID: 12535648
[TBL] [Abstract][Full Text] [Related]
32. TGFbeta receptor types I and II and the substrate proteins Smad 2 and 3 are present in human oocytes.
Osterlund C; Fried G
Mol Hum Reprod; 2000 Jun; 6(6):498-503. PubMed ID: 10825365
[TBL] [Abstract][Full Text] [Related]
33. Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-beta pathways.
Sapkota G; Knockaert M; Alarcón C; Montalvo E; Brivanlou AH; Massagué J
J Biol Chem; 2006 Dec; 281(52):40412-9. PubMed ID: 17085434
[TBL] [Abstract][Full Text] [Related]
34. Structural basis of Smad2 recognition by the Smad anchor for receptor activation.
Wu G; Chen YG; Ozdamar B; Gyuricza CA; Chong PA; Wrana JL; Massagué J; Shi Y
Science; 2000 Jan; 287(5450):92-7. PubMed ID: 10615055
[TBL] [Abstract][Full Text] [Related]
35. Growth inhibitory signalling by TGFbeta is blocked in Ras-transformed intestinal epithelial cells at a post-receptor locus.
Jiang B; Zhang JS; Du J; Urrutia R; Barnard J
Cell Signal; 2003 Jul; 15(7):699-708. PubMed ID: 12742230
[TBL] [Abstract][Full Text] [Related]
36. Smad2 phosphorylation by type I receptor: contribution of arginine 462 and cysteine 463 In the C terminus of Smad2 for specificity.
Yakymovych I; Heldin CH; Souchelnytskyi S
J Biol Chem; 2004 Aug; 279(34):35781-7. PubMed ID: 15210694
[TBL] [Abstract][Full Text] [Related]
37. Smad1 recognition and activation by the ALK1 group of transforming growth factor-beta family receptors.
Chen YG; Massagué J
J Biol Chem; 1999 Feb; 274(6):3672-7. PubMed ID: 9920917
[TBL] [Abstract][Full Text] [Related]
38. Complementary IL-23 and IL-27 anti-tumor activities cause strong inhibition of human follicular and diffuse large B-cell lymphoma growth in vivo.
Cocco C; Di Carlo E; Zupo S; Canale S; Zorzoli A; Ribatti D; Morandi F; Ognio E; Airoldi I
Leukemia; 2012 Jun; 26(6):1365-74. PubMed ID: 22193967
[TBL] [Abstract][Full Text] [Related]
39. Activin receptor-like kinase 2 and Smad6 regulate epithelial-mesenchymal transformation during cardiac valve formation.
Desgrosellier JS; Mundell NA; McDonnell MA; Moses HL; Barnett JV
Dev Biol; 2005 Apr; 280(1):201-10. PubMed ID: 15766759
[TBL] [Abstract][Full Text] [Related]
40. Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity.
Ozdamar B; Bose R; Barrios-Rodiles M; Wang HR; Zhang Y; Wrana JL
Science; 2005 Mar; 307(5715):1603-9. PubMed ID: 15761148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
